Stock comparison
Integra LifeSciences
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IART
Integra LifeSciences
Market cap
$1.17B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IART | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 26F | 69B | MTD |
| Benjamin Graham | 40D | 65B | MTD |
| Philip Fisher | 23F | 63C | MTD |
| Peter Lynch | 21F | 66B | MTD |
| Joel Greenblatt | 40D | 68B | MTD |
| Charlie Munger | 22F | 74B | MTD |
| Terry Smith | 15F | 70B | MTD |
Side-by-side metrics
| Metric | IART | MTD |
|---|---|---|
| Market cap | $1.17B | $22.29B |
| P/E (TTM) | - | 25.3x |
| EV/EBIT | 42.6x | 21.6x |
| ROIC (TTM) | 3.49% | 36.09% |
| Gross margin | 53.21% | 57.79% |
| Net margin | -30.15% | 21.4% |
| Revenue CAGR 5y | 1.47% | 2.01% |
| EPS CAGR 5y | - | 6.12% |
| Debt / Equity | 2.0x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IART leads on
- P/E (TTM)-vs 25.3x+109%
MTD leads on
- Net margin21.4%vs -30.15%+171%
- Debt / Equity-vs 2.0x+104%
- Market cap$22.29Bvs $1.17B+95%
- ROIC (TTM)36.09%vs 3.49%+90%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.